COMMENTARY: Adjuvant vs Neoadjuvant for Resectable NSCLC?

Which is better? Concurrent neoadjuvant chemotherapy and immunotherapy or concurrent adjuvant chemotherapy with immunotherapy for non–small cell lung cancer (NSCLC)?
Medscape Medical News